Recombinant Human FAM49B protein (His tag N-Terminus)
Be the first to review this product! Submit a review
|
(0 Publication)
Recombinant Human FAM49B protein (His tag N-Terminus) is a Human Full Length protein, in the 1 to 324 aa range, expressed in Escherichia coli, with >90%, suitable for SDS-PAGE, Mass Spec.
View Alternative Names
CYRI, FAM49B, BM-009, CYRIB, CYFIP-related Rac1 interactor B, L1
- SDS-PAGE
Unknown
SDS-PAGE - Recombinant Human FAM49B protein (His tag N-Terminus) (AB140726)
15% SDS-PAGE analysis of ab140726 (3μg).
Reactivity data
Sequence info
Properties and storage information
Shipped at conditions
Appropriate short-term storage duration
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Specifications
Form
Liquid
Additional notes
ab140726 is purified using conventional chromatography techniques.
General info
Function
Negatively regulates RAC1 signaling and RAC1-driven cytoskeletal remodeling (PubMed : 30250061, PubMed : 31285585). Regulates chemotaxis, cell migration and epithelial polarization by controlling the polarity, plasticity, duration and extent of protrusions. Limits Rac1 mediated activation of the Scar/WAVE complex, focuses protrusion signals and regulates pseudopod complexity by inhibiting Scar/WAVE-induced actin polymerization (PubMed : 30250061). Protects against Salmonella bacterial infection. Attenuates processes such as macropinocytosis, phagocytosis and cell migration and restrict sopE-mediated bacterial entry (PubMed : 31285585). Restricts also infection mediated by Mycobacterium tuberculosis and Listeria monocytogenes (By similarity). Involved in the regulation of mitochondrial dynamics and oxidative stress (PubMed : 29059164).
Sequence similarities
Belongs to the CYRI family.
Post-translational modifications
Ubiquitinated at Lys-74 upon Salmonella bacterial infection.
Subcellular localisation
Mitochondrion
Target data
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com